Innovation of HTA Methods. How Can the IHTAM Framework, Developed By HTx Project, Support the Introduction, Development, and Implementation of New HTA Methods in HTA Practice?
Author(s)
Moderator: Wim Goettsch, PhD, National Health Care Institute (ZIN); Utrecht University, Division of Pharmacoepidemiology and Clinical Pharmacology, Diemen, Netherlands
Panelists: Junfeng Wang, PhD, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Bilthoven, Netherlands; Oresta Piniazhko, PhD, HTA Department, SEC of Ministry of Health, Kyiv, Ukraine; Gracy Crane, PhD, Regulatory Policy Group, Roche Pharmaceuticals UK, Camberley, UK
Presentation Documents
ISSUE: Can the Innovation of Health Technologies Assessment Methods (IHTAM) framework, as developed by the H2020 HTx project, help to improve the development and implementation of new HTA methods in HTA practice?
OVERVIEW:
Adequate methods are urgently needed to guarantee the good practice of health technology assessment (HTA) for technologies with novel properties. As part of the H2020 HTx project we constructed a conceptual framework to improve the innovation of HTA methods (IHTAM)1. The framework was constructed based on twenty documents on innovating HTA frameworks and fourteen guidelines from three scientific disciplines and includes a generic innovation process consisting of three phases ("Identification," "Development," and "Implementation") and nine subphases. In the framework, three roles that HTA stakeholders can play in innovation ("Developers," "Practitioners," and "Beneficiaries") are defined, and a process on how the stakeholders innovate HTA methods is included. The IHTAM framework visualizes systematically which elements and stakeholders are important to the development and implementation of novel HTA methods. In this panel, we want to discuss with academy, HTA bodies and practitioners and industry whether this IHTAM framework could provide an important tool for improving and implementing HTA methods and which roles they can take in the innovation process. We will use several examples of innovative HTA methods (for instance evidence synthesis based on RCT and RWD or machine learning/artificial a intelligence methods) and assess how this fits the IHTAM framework and benefit the different stakeholder groups in different settings around Europe. 1Jiu L, Hogervorst MA, Vreman RA, Mantel-Teeuwisse AK, Goettsch WG (2022). Understanding innovation of health technology assessment methods: the IHTAM framework. International Journal of Technology Assessment in Health Care 38, e16, 1-10.Conference/Value in Health Info
2022-11, ISPOR Europe 2022, Vienna, Austria
Code
240
Topic
Health Technology Assessment